Precion LLC

Precion specializes in the development, validation, and profiling of LC-MS/MS based small molecule biomarker assays. Precion’s method, a metabolite based test, reveals what is actually happening. Partner with Precion and let our team develop your next superior assay. We are pioneers in the biomarker field and strive for excellence with accuracy and development of assays. Precion specializes in the development, validation, and profiling of LC-MS/MS based small molecule biomarker assays and our in-house synthesis capabilities for stable isotope labeled internal standards allow for accurate, dependable, and reproducible results. Our focus on targeting metabolites allow us to diagnose chronic disease effectively. Innovative testing, a strong R&D pipeline, and an extensive patent portfolio makes our products unique. Allowing us the ability to deep profile key disease pathways, provide robust biomarker selection, and access to critical clinical resources.